This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 200406-740OCv1 171/9/1026    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sermet-Gaudelus, I. Articles by Edelman, A. Search for Related Content PubMed PubMed Citation Articles by Sermet-Gaudelus, I. Articles by Edelman, A.

Chloride Transport in Nasal Ciliated Cells of Cystic Fibrosis Heterozygotes

Centre de Ressources et de Compétences en Mucoviscidose, Laboratoire d'Explorations Fonctionnelles Rénales, Service de Biochimie A, Service d'ORL, and Centre d'Investigation Clinique, Hôpital Necker-Enfants Malades; INSERM U 467, Université Paris 5; Service d'Histologie-Biologie Tumorale, Hôpital Tenon, Paris; and Service de Biochimie-Génétique, Hôpital Henri Mondor, and INSERM U 468, Créteil, France

Correspondence and requests for reprints should be addressed to Aleksander Edelman, Ph.D., INSERM U 467, Faculté de Médecine Necker, 156 rue de Vaugirard, Paris 75730, France. E-mail: edelman{at}necker.fr

Studying subjects heterozygous for mutations of the cystic fibrosis (CF) gene may help clarify the impact on disease onset of CF transmembrane conductance regulator protein (CFTR-)–dependent chloride secretion. CFTR-mediated chloride transport was evaluated in 52 heterozygous subjects, 32 healthy control subjects, and 77 patients with CF with class I or II mutations. We measured the change in nasal potential difference in response to chloride-free isoproterenol solution for each subject and used a video-imaging fluorescent dye assay to assess the percentage of nasal ciliated cells with cAMP-dependent anion conductance. Our findings did not confirm the standard assumption that heterozygosity implies 50% of normal CFTR function. Half the heterozygous subjects had CFTR-mediated chloride transport levels below 50% of the normal range, and one-third had levels similar to those of the patients with CF. This reduced CFTR function was not associated with an elevated prevalence of CF-like symptoms in heterozygous subjects but was highly related to respiratory status in the patients with CF. These data suggest that CFTR-dependent chloride conductance does not directly modulate disease severity but may be part of a more global defect in patients with CF involving other CFTR functions or currently unknown modulatory factors.

Key Words: cystic fibrosis transmembrane conductance regulator • heterozygosity • nasal potential difference

This article has been cited by other articles:

				J. Xu, P. Song, M. L. Miller, F. Borgese, S. Barone, B. Riederer, Z. Wang, S. L. Alper, J. G. Forte, G. E. Shull, et al. Deletion of the chloride transporter Slc26a9 causes loss of tubulovesicles in parietal cells and impairs acid secretion in the stomach PNAS, November 18, 2008; 105(46): 17955 - 17960. [Abstract] [Full Text] [PDF]

				S. M. Rowe, F. Accurso, and J. P. Clancy Detection of Cystic Fibrosis Transmembrane Conductance Regulator Activity in Early-Phase Clinical Trials Proceedings of the ATS, August 1, 2007; 4(4): 387 - 398. [Abstract] [Full Text] [PDF]

				F. J. Accurso Update in cystic fibrosis 2005. Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 944 - 947. [Full Text] [PDF]